Dr. Elizabeth Mcmillan Green Malone, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 206 Elliott Rd, Lyman, SC 29365 Phone: 864-439-6559 Fax: 864-439-1905 |
Dr. William Malone, DMD Dentist Medicare: Medicare Enrolled Practice Location: 206 Elliott Rd, Lyman, SC 29365 Phone: 864-439-6559 Fax: 864-439-1905 |
Dr. David Everett Yoder, D.M.D Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 350 Spartanburg Hwy, Lyman, SC 29365 Phone: 864-439-0023 Fax: 864-439-9112 |
Dr. Brian Kingston Armstrong, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 350 S Spartanburg Hwy, Lyman, SC 29365 Phone: 864-439-0023 Fax: 864-439-9112 |
Kirk Edward Houston, DMD PA Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 12313 Greenville Hwy, Lyman, SC 29365 Phone: 864-439-3322 Fax: 864-949-3953 |
News Archive
Researchers from Kingston University and St George's, University of London are examining whether hourly ward rounds really do help nurses deliver safe, compassionate, patient-centred care.
Rubicon Genomics today announced that its PicoPlex linear whole genome amplification technology was proven to be effective in an independent clinical study organized by the European Society for Human Reproduction and Embryology. At a press conference during its 26th Annual Meeting in Rome, ESHRE reported the success of its "groundbreaking proof of principle study" showing that a new approach incorporating PicoPlex could more accurately detect and characterize chromosomal abnormalities in human eggs.
"In today's world, the majority of deaths go unregistered," but "the information that comes from accurate and complete records of deaths - who died, and why - constitutes a huge resource for evidence-based health planning and development," Peter Byass, a professor of global health at Umea University in Sweden and director of the Umea Centre for Global Health Research, writes in this post in the PLoS "Speaking of Medicine" blog.
Providing supervised access to medical-grade heroin to people whose use continues after trying multiple traditional treatments has been successful in other countries, and should be piloted and studied in the United States, according to a new RAND Corporation study.
FDA put on display today a Federal Register notice seeking public comment on a proposal for withdrawing "essential-use" status for albuterol metered-dose inhalers (MDIs) using chlorofluorocarbon (CFC) propellants.
› Verified 3 days ago